Wave Life Sciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell WVE and other ETFs, options, and stocks.

About WVE

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas.

CEO

Paul B. Bolno

CEOPaul B. Bolno

Employees

288

Employees288

Headquarters

Singapore, Central Singapore

HeadquartersSingapore, Central Singapore

Founded

2012

Founded2012

Employees

288

Employees288

WVE Key Statistics

Market cap

1.31B

Market cap1.31B

Price-Earnings ratio

-9.26

Price-Earnings ratio-9.26

Dividend yield

—

Dividend yield—

Average volume

2.44M

Average volume2.44M

High today

$9.75

High today$9.75

Low today

$7.34

Low today$7.34

Open price

$7.55

Open price$7.55

Volume

17.35M

Volume17.35M

52 Week high

$16.74

52 Week high$16.74

52 Week low

$5.28

52 Week low$5.28

WVE News

TipRanks 7h

Wave Life Sciences Reports Positive INLIGHT Trial Results

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 9h

Wave Life ‘at cusp of new era’ in healthy weight loss, says Truist

Truist reiterated a Buy rating and $36 price target on Wave Life Sciences (WVE) after the company presented new data from its WVE-007 weight loss treatment stud...

Analyst ratings

94%

of 16 ratings

Buy

93.8%

Hold

6.3%

Sell

People also own

Based on the portfolios of people who own WVE. This list is generated using Robinhood data, and it’s not a recommendation.